BUSINESS HEALTH
UnknownFinancial checks not available.
EQUITY INTELLIGENCE US MARKETS
Clarity before
conviction.
Research a ticker. See the signal, the evidence, and the risks — without the noise.
EXPERIMENTAL TOOLStock research shortlistProvisional screening only · validation is incomplete
DATA-DRIVEN STOCK SUGGESTIONS
Top 10 research candidates
The experimental watchlist score ranks research priorities only. Preliminary valuation-based watch zones may appear in the analysis panel when inputs pass quality checks, but they are provisional research signals only; full historical validation remains incomplete.
The system screens a curated universe of 253 US stocks and displays up to ten ranked research candidates. Latest quote and valuation checks may provide a provisional model entry watch zone, fair-value reference, risk reference, and a 1–6 month review horizon. These are research references only, not guaranteed buy/exit instructions. The strategy has not passed walk-forward and untouched holdout validation.
YOUR MARKET SNAPSHOT
Loading latest snapshot when openedTop 10 stocks to research
Fast, precomputed shortlist from the latest 253-stock scan. Refreshes every three hours; open any stock for live checks.
Your latest shortlist will appear here. Select “Show latest top 10” to load the cached scan.
Scoring method
Revenue growth: 25 points. Net profit margin: 15 points. Approximate free-cash-flow margin: 20 points. One-year price return: 20 points. Maximum drawdown: 20 points. A candidate is excluded if any component is missing or ambiguous. Scores rank research priorities only; valuation, event risk, and walk-forward validation are not yet part of this score.
Data connection details
Page: Loaded
SEC connection: Not tested yet
Alpaca Paper Trading
Not checked yet
Secure server-side connection. Read-only: Northstar will not place trades.
Last request: —
Financial facts come from SEC EDGAR. This is a research prototype, not a valuation model or trade recommendation.